Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02329782 · ClinicalTrials.gov registry record · NA
Supporting Treatment Adherence Readiness Through Training (START)
A NA study of HIV Medication Adherence, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 3
- Study locations
NCT02329782: Completed NA study of HIV Medication Adherence, sponsored by RAND.
NCT02329782 is a NA study of HIV Medication Adherence that has completed, run by RAND. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02329782, a NA study of HIV Medication Adherence, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 3
- Study locations
Study Summary
Multi-site, randomized controlled trial of the Adherence Readiness Program (ARP) adherence intervention for HIV clients starting or restarting antiretroviral therapy (ART) for the purpose of achieving and sustaining optimal levels of ART adherence and virologic suppression. Eligible participants will be randomized to receive either the ARP intervention or usual care (no intervention) and followed for 24 months.
Primary Outcome
undetectable HIV viral load at time of assessment
Conditions Studied
Interventions
- BEHAVIORAL Adherence Readiness Program
Study Locations (3)
California
- CARE CLinic - Long Beach
- T.H.E. Clinic - Los Angeles
- UCLA Care Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2015-02 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
What the finished NCT02329782 record still lists
NCT02329782 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with HIV Medication Adherence appearing as the primary indexed condition, and to 1 intervention - of which Adherence Readiness Program is the first listed.
NCT02329782 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02329782 about?
NCT02329782 is a clinical study titled "Supporting Treatment Adherence Readiness Through Training (START)". Multi-site, randomized controlled trial of the Adherence Readiness Program (ARP) adherence intervention for HIV clients starting or restarting antiretroviral therapy (ART) for the purpose of achieving and sustaining optimal levels of ART adherence and virologic suppression. Eligible participants wil...
What is the current status of trial NCT02329782?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2015-02. Estimated completion is 2020-03-30.
What conditions does trial NCT02329782 study?
This clinical trial studies the following conditions: HIV Medication Adherence.
What interventions are being tested in trial NCT02329782?
The interventions under investigation include: Adherence Readiness Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02329782?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02329782 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02329782's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia